Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-IFNW1 Antibody (R2Y90)

Catalog #:   RHC11601 Specific References (45) DATASHEET
Host species: Mouse
Isotype: IgG1
Applications: WB
Accession: P05000
Overview

Catalog No.

RHC11601

Species reactivity

Human

Host species

Mouse

Isotype

IgG1

Clonality

Monoclonal

Tested applications

WB: 1:500-1:1000

Target

IFNW1, Interferon alpha-II-1, Interferon omega-1

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P05000

Applications

WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% Sodium Azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

R2Y90

Data Image
References

Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths., PMID:34413139

Multiplex Autoantibody Detection in Patients with Autoimmune Polyglandular Syndromes., PMID:34071130

Mild COVID-19 despite autoantibodies against type I IFNs in autoimmune polyendocrine syndrome type 1., PMID:34061776

Autoimmune polyendocrine syndrome type 1: an Italian survey on 158 patients., PMID:34003463

Severe COVID-19 in an APS1 patient with interferon autoantibodies treated with plasmapheresis., PMID:33892926

Vasculitis as a Major Morbidity Factor in Patients With Partial RAG Deficiency., PMID:33193364

Autoantibodies against type I IFNs in patients with life-threatening COVID-19., PMID:32972996

Antiviral Effects of Hydroxychloroquine and Type I Interferon on In Vitro Fatal Feline Coronavirus Infection., PMID:32456286

Egyptian Rousette IFN-ω Subtypes Elicit Distinct Antiviral Effects and Transcriptional Responses in Conspecific Cells., PMID:32231668

The heterogeneity of autoimmune polyendocrine syndrome type 1: Clinical features, new mutations and cytokine autoantibodies in a Brazilian cohort from tertiary care centers., PMID:30287219

HPV11 E6 mutation by overexpression of APOBEC3A and effects of interferon-ω on APOBEC3s and HPV11 E6 expression in HPV11.HaCaT cells., PMID:29100527

Assessment of autoantibodies to interferon-ω in patients with autoimmune polyendocrine syndrome type 1: using a new immunoprecipitation assay., PMID:28099118

Characterization and antivirus activities of a novel bovine IFN-omega24., PMID:25951414

Oral and subcutaneous therapy of canine atopic dermatitis with recombinant feline interferon omega., PMID:24548425

[Preparation and characterization of mono PEGylated recombinant human interferon omega]., PMID:22645765

Use of recombinant interferon omega in feline retrovirosis: from theory to practice., PMID:21719116

Preparation of CHO cell-derived rhIFN-ω-Fc with improved pharmacokinetics., PMID:21277904

AIRE gene mutations and autoantibodies to interferon omega in patients with chronic hypoparathyroidism without APECED., PMID:20718774

Human plasmacytoid dendritic cell accumulation amplifies their type 1 interferon production., PMID:20346735

Autoimmune polyendocrinopathy-candidosis-ectodermal dystrophy (APECED)--a diagnostic and therapeutic challenge., PMID:20118890

Novel sequence variation of AIRE and detection of interferon-omega antibodies in early infancy., PMID:19863576

Radioimmunoassay for autoantibodies against interferon omega; its use in the diagnosis of autoimmune polyendocrine syndrome type I., PMID:18708298

Pretreatment with feline interferon omega and the course of subsequent infection with feline herpesvirus in cats., PMID:17760705

Evaluation of inflammation and immunity in cats with spontaneous parvovirus infection: consequences of recombinant feline interferon-omega administration., PMID:17521745

Safety pharmacology, toxicology and pharmacokinetic assessment of recombinant human omega-interferon produced from CHO-SS cells., PMID:16867173

Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1., PMID:16784312

Anti-interferon auto-antibodies in autoimmune polyendocrinopathy syndrome type 1., PMID:16756392

Activity of feline interferon-omega after ocular or oral administration in cats as indicated by Mx protein expression in conjunctival and white blood cells., PMID:16740097

Incidence of autoantibodies against type I and type II interferons in a cohort of systemic lupus erythematosus patients in Slovakia., PMID:12716486

Anti-cytokine autoantibodies in autoimmunity: preponderance of neutralizing autoantibodies against interferon-alpha, interferon-omega and interleukin-12 in patients with thymoma and/or myasthenia gravis., PMID:12653847

Receptors for recombinant feline interferon-omega in hemocytes of the Japanese pearl oyster Pinctada fucata martensii., PMID:12363085

Identification of critical residues in bovine IFNAR-1 responsible for interferon binding., PMID:11278538

Sodium phosphate enhances plasmid DNA expression in vivo., PMID:10918485

Are all type I human interferons equivalent?, PMID:9658366

Natural autoantibodies to interferons., PMID:9241617

A comparison of the antiproliferative properties of recombinant human IFN-alpha 2 and IFN-omega in human bone marrow culture., PMID:9197999

An anti-cytokine bioactivity assay for interferons-alpha, -beta and -omega., PMID:8814320

Human interferon omega--a review., PMID:9345398

Interferon alpha induces rapid tyrosine phosphorylation of the vav proto-oncogene product in hematopoietic cells., PMID:7508909

A monoclonal antibody to recombinant human IFN-alpha receptor inhibits biologic activity of several species of human IFN-alpha, IFN-beta, and IFN-omega. Detection of heterogeneity of the cellular type I IFN receptor., PMID:8423335

Human interferon omega 1: isolation of the gene, expression in Chinese hamster ovary cells and characterization of the recombinant protein., PMID:1647209

Are the acid-labile interferon alpha and interferon omega-1 identical?, PMID:1994590

Purification and characterization of natural human interferon omega 1. Two alternative cleavage sites for the signal peptidase., PMID:1693148

Monoclonal antibodies and enzyme immunoassays specific for human interferon (IFN) omega 1: evidence that IFN-omega 1 is a component of human leukocyte IFN., PMID:1691561

Antigenic structure of human interferon omega 1 (interferon alpha II1): comparison with other human interferons., PMID:2438379

Datasheet

Document Download

Anti-IFNW1 Antibody (R2Y90).pdf

 

$ 220
Product specifications
50 μg 220 100 μg 350

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-IFNW1 Antibody (R2Y90) [RHC11601]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only